Search research articles
Contact Us
Filters
Showing results (171-180 of 188) with videos related to
Page
of 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2013
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
R A Popescu, R Schäfer, R Califano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2016
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
F Ciardiello, N Normanno, E Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2024
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF<sup>V600E</sup> wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial
D Ciardiello, L Boscolo Bielo, S Napolitano, et al.
ESMO Open
|
January 5, 2023
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
C Cardone, A De Stefano, G Rosati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2017
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
T Yoshino, D Arnold, H Taniguchi, et al.
ESMO Open
|
January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A Gravina, P Gargiulo, M De Laurentiis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
E Van Cutsem, M Dicato, N Arber, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer
V De Falco, P P Vitiello, D Ciardiello, et al.
ESMO Open
|
April 29, 2023
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
G Martini, V Belli, S Napolitano, et al.
ESMO Open
|
August 22, 2022
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM)
D Ciardiello, C Chiarazzo, V Famiglietti, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 188) with videos related to
Sort By:
Page
of 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2013
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
R A Popescu, R Schäfer, R Califano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2016
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
F Ciardiello, N Normanno, E Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2024
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF<sup>V600E</sup> wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial
D Ciardiello, L Boscolo Bielo, S Napolitano, et al.
ESMO Open
|
January 5, 2023
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
C Cardone, A De Stefano, G Rosati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2017
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
T Yoshino, D Arnold, H Taniguchi, et al.
ESMO Open
|
January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A Gravina, P Gargiulo, M De Laurentiis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
E Van Cutsem, M Dicato, N Arber, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer
V De Falco, P P Vitiello, D Ciardiello, et al.
ESMO Open
|
April 29, 2023
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
G Martini, V Belli, S Napolitano, et al.
ESMO Open
|
August 22, 2022
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM)
D Ciardiello, C Chiarazzo, V Famiglietti, et al.
Page
of 19